Warning: Undefined array key "key" in /confereneceLV/conferenece_com/conferenceseries_com/ga-analytics.php on line 2

Warning: Undefined variable $subject_array in /confereneceLV/conferenece_com/conferenceseries_com/ga-analytics.php on line 15

Warning: Trying to access array offset on value of type null in /confereneceLV/conferenece_com/conferenceseries_com/ga-analytics.php on line 15

Warning: Trying to access array offset on value of type null in /confereneceLV/conferenece_com/conferenceseries_com/ga-analytics.php on line 15

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Lyme Borreliosis

Lyme Borreliosis


As per available reports about 10 relevant journals, 15 Conferences, 30 workshops are presently dedicated exclusively to lyme borreliosis and about 2,070 articles are being published on lyme borreliosis. 

Lyme borreliosis(Lyme disease) is an infectious disease caused by three species of bacteria belonging to the genus Borrelia. It is transmitted via the bite of an infected tick. Early symptoms may include fever, headache, and fatigue. A rash occurs in 70–80% of infected persons at the site of the bite after a delay of 3–30 days (average is about 7 days), and may or may not appear as the well-publicized bull's-ocular perceiver (erythema migrans). The rash is infrequently painful or itchy, albeit it may be warm to the physical contact. About 20–30% of infected persons do not experience a rash. Left untreated, later symptoms may involve the joints, heart, and central nervous system. In most cases, the infection and its symptoms are eliminated by antibiotics, especially if the illness is treated early. Delayed or inadequate treatment can lead to more solemn symptoms, which can be incapacitating and arduous to treat.

Borrelia burgdorferi sensu stricto is the main cause of Lyme disease in North America, whereas Borrelia afzelii and Borrelia garinii cause most European cases. Borrelia is transmitted to humans by the bite of infected ticks belonging to a few species of the genus Ixodes ("hard ticks"). Lyme disease is the most mundane tick-borne disease in the Northern Hemisphere.
The term "chronic Lyme disease" is controversial and not apperceived in the medical literature, and most medical ascendant entities advise against long-term antibiotic treatment for "chronic Lyme disease".
 

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Lyme borreliosis  is transmitted via the bite of an infected tick. Early symptoms may include fever, headache, and fatigue. A rash occurs in 70–80% of infected persons at the site of the bite after a delay of 3–30 days (average is about 7 days), and may or may not appear as the well-publicized bull's-ocular perceiver (erythema migrans). The rash is infrequently painful or itchy, albeit it may be warm to the physical contact. About 20–30% of infected persons do not experience a rash. 

Conferences :


Socities :
• American Society for Microbiology
• Society for Applied Microbiology- UK
• International Union of Microbiological Societies
• Society for General Microbiology Journals
• American Society for Microbiology Career Connections
• The Canadian Society of Microbiologists
• European Microbiological Society.
• Illinois Society of Microbiology
• British Society for Microbial Technology
• New Zealand Microbological Society

Companies:
• Pfizer
• Novartis
• Roche
• Merck & Co.
• Sanofi
• GlaxoSmithKline
• Johnson & Johnson
• AstraZeneca
• Lilly
• AbbVie

This page will be updated regularly.

This page was last updated on March 29, 2024

Conference Series Destinations